Erick J. Lucera
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Erick J. Lucera
Erick J. Lucera is recorded as CFO at Editas Medicine, Inc. (EDIT). Editas Medicine, Inc. reported in an 8-K filed May 17, 2023 that Erick J. Lucera was appointed Executive Vice President and Chief Financial Officer, effective May 17, 2023.
“On May 16, 2023, Editas Medicine, Inc. (the “Company”) appointed Erick J. Lucera as Executive Vice President and Chief Financial Officer of the Company, effective May 17, 2023, succeeding Michelle Robertson as Executive Vice President and Chief Financial Officer of the Company, who stepped down as the Company’s Chief Financial Officer effective May 16, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-17–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Editas Medicine, Inc.
Other people whose current roles at this company are on record from its filings.
- Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
- James C. Mullen CEO
- Katrine S. Bosley CEO
- Jessica Hopfield Chairman
- Amy Parison CFO
- Andrew A. F. Hack CFO
- Eric Ek CFO
- Vic Myer CTO
- Bernadette Connaughton Board Member
- David Scadden, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.